medicinal chemistry
154 projects
FP7Reintegration grant2010–2014Greece
COMPUT DRUG DESIGN · Targeting the mutated PI3Kα isoform for the development of novel anti-cancer agents
FP7Doctoral network2009–2013Netherlands
STARS · Scientific Training in Antimicrobial Research Strategies
7 partners · 5 countries
FP7Individual fellowship2009–2011Portugal
CYCLOTIDE MECHANISM · Elucidating the mechanism of action of cyclotides: ultra-stable proteins from plants
FP7Individual fellowship2009–2010Switzerland
STOADA · Synthesis of Targeted Organometallic Anticancer Drugs and their mode of Action
FP7Staff exchange2009–2013Portugal
PEP2BRAIN · Selected peptides as drug candidates directed to pain and neurodegeneration
5 partners · 3 countries
FP7Reintegration grant2009–2013Spain
AR BF3 BINDERS · Identification of the protein binders of the androgen receptor BF3 pocket, an allosteric modulator of AF2 coactivator recruitment
FP7Staff exchange2008–2012Greece
TOPCRYST · Novel tools for crystallisation of macromolecules
3 partners · 2 countries
FP6Individual fellowship2007–2008France
MTDI-DNA · Molecular Theory of Drug Intercalation into DNA
FP6Individual fellowship2007–2008United Kingdom
DRUG-DISCOVERY · Synthesis and screening of new small molecules with antibacterial activity: Discovery of novel biological targets
FP6Individual fellowship2006–2008Germany
PHYTOPHARM · Phytochemical and Pharmacological Study of Plants Used in Traditional Medicine in Cameroon
FP6Individual fellowship2006–2008Denmark
MODELING PH-DEPENCE · Modelling pH-Dependence in rational drug design
FP6Individual fellowship2006–2009United Kingdom
SPIROTENUIPESINES · Total Synthesis of the Potent Neurotrophic Factors Spirotenuipesine A and B
2 partners · 2 countries
FP6Individual fellowship2006–2008United Kingdom
P53MUT. REACTIVATORS · Computer-assisted drug discovery and biophysical characterisation of mutant re-activators of the transcription factor p53 as putative tumour therapeutics
FP6Reintegration grant2006–2008Lithuania
PLK1 INHIBITION · Inhibition of Cancer by Disrupting Interaction Between Polo-like Kinase 1 Polo-box Domain and Spindle Targets
FP6Doctoral network2006–2010France
BIOMEDCHEM · Training for new approaches in anti-parasite and anti-tumour drug discovery
FP6Individual fellowship2006–2010United Kingdom
MEDCHEM AT QUB/GSK · New methodologies to synthetise unnatural nucleosides, known and putative antiproliferative agents
FP6Individual fellowship2005–2007Germany
COMBINE-ENGINEER · A software tool for molecular design using protein structure-based quantitative structure activity relationships
FP6Other2005–2007Italy
PHARMAMAL · Investigation of the mechanism of action of antimalarial agents, by means of computational methods. Bases for the rational design of new antimalarial drugs
FP6Individual fellowship2005–2007United Kingdom
POLYKETOMACROCYCLES · Transannular Macrocyclisation and the concise total synthesis of Antifungal natural products
FP6Doctoral network2005–2009Italy
FOLDAMERS · Design, synthesis, Structural Characterization and biological evaluation of new peptidomimetics with a defined secondary structure
3 partners · 3 countries
FP6Staff exchange2004–2008Germany
SMARTSCREEN · Magnetic resonance in drug screening
4 partners · 4 countries
FP6Staff exchange2004–2008France
MET-CANCER THERAPY · Animal models and drug design for therapy of cancers induced by the oncogene, met
FP6Individual fellowship2004–2008Denmark
NAC-DRUG · Nucleic Acid Based Drug Design Training Center
FP6Individual fellowship2004–2006United Kingdom
